Study of the effectiveness of the drug Laennek in case of liver damage by palm oil in rats

Palm oil is a component of most food products, characterized by a high content of palmitic and oleic acids, an excess of which leads to the formation of tripalmitins, practically do not respond to enzymatic hydrolysis by lipoprotein lipase and predetermine the development of obesity, type 2 diabetes...

Full description

Saved in:
Bibliographic Details
Main Authors: T. E. Bogacheva, A. G. Kalacheva, O. A. Gromova, I. Yu. Torshin, T. R. Grishina, V. I. Demidov
Format: Article
Language:Russian
Published: LLC “Publisher OKI” 2024-01-01
Series:Фармакокинетика и Фармакодинамика
Subjects:
Online Access:https://www.pharmacokinetica.ru/jour/article/view/389
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849344888934498304
author T. E. Bogacheva
A. G. Kalacheva
O. A. Gromova
I. Yu. Torshin
T. R. Grishina
V. I. Demidov
author_facet T. E. Bogacheva
A. G. Kalacheva
O. A. Gromova
I. Yu. Torshin
T. R. Grishina
V. I. Demidov
author_sort T. E. Bogacheva
collection DOAJ
description Palm oil is a component of most food products, characterized by a high content of palmitic and oleic acids, an excess of which leads to the formation of tripalmitins, practically do not respond to enzymatic hydrolysis by lipoprotein lipase and predetermine the development of obesity, type 2 diabetes mellitus and atherosclerosis. This paper presents the results of a study of the drug Laennek, produced on the basis of standardized hydrolysates of the human placenta (HRP). The use of HRP under the influence of excessive consumption of palm oil in the diet led to a significant decrease in markers of liver dysfunction (ALT), which increase with an enriched diet of refined palm oil (bilirubin, total protein, ALT, AST). The hepatoprotective effect of Laennek was confirmed by the results of histological and biochemical studies indicating a decrease in the severity and prevalence of fatty liver dystrophy.
format Article
id doaj-art-ad42e4c42de74c6bb8dd7c7f16dada50
institution Kabale University
issn 2587-7836
2686-8830
language Russian
publishDate 2024-01-01
publisher LLC “Publisher OKI”
record_format Article
series Фармакокинетика и Фармакодинамика
spelling doaj-art-ad42e4c42de74c6bb8dd7c7f16dada502025-08-20T03:42:33ZrusLLC “Publisher OKI”Фармакокинетика и Фармакодинамика2587-78362686-88302024-01-0104233110.37489/2587-7836-2023-4-23-31352Study of the effectiveness of the drug Laennek in case of liver damage by palm oil in ratsT. E. Bogacheva0A. G. Kalacheva1O. A. Gromova2I. Yu. Torshin3T. R. Grishina4V. I. Demidov5FSBEI HE "Ivanovo State Medical Academy" MOH RussiaFSBEI HE "Ivanovo State Medical Academy" MOH RussiaFRC "Computer Science and Control" RASFRC "Computer Science and Control" RASFSBEI HE "Ivanovo State Medical Academy" MOH RussiaFSBEI HE "Ivanovo State Medical Academy" MOH RussiaPalm oil is a component of most food products, characterized by a high content of palmitic and oleic acids, an excess of which leads to the formation of tripalmitins, practically do not respond to enzymatic hydrolysis by lipoprotein lipase and predetermine the development of obesity, type 2 diabetes mellitus and atherosclerosis. This paper presents the results of a study of the drug Laennek, produced on the basis of standardized hydrolysates of the human placenta (HRP). The use of HRP under the influence of excessive consumption of palm oil in the diet led to a significant decrease in markers of liver dysfunction (ALT), which increase with an enriched diet of refined palm oil (bilirubin, total protein, ALT, AST). The hepatoprotective effect of Laennek was confirmed by the results of histological and biochemical studies indicating a decrease in the severity and prevalence of fatty liver dystrophy.https://www.pharmacokinetica.ru/jour/article/view/389palm oilsteatohepatosishuman placenta hydrolysateslaennechepatoprotection
spellingShingle T. E. Bogacheva
A. G. Kalacheva
O. A. Gromova
I. Yu. Torshin
T. R. Grishina
V. I. Demidov
Study of the effectiveness of the drug Laennek in case of liver damage by palm oil in rats
Фармакокинетика и Фармакодинамика
palm oil
steatohepatosis
human placenta hydrolysates
laennec
hepatoprotection
title Study of the effectiveness of the drug Laennek in case of liver damage by palm oil in rats
title_full Study of the effectiveness of the drug Laennek in case of liver damage by palm oil in rats
title_fullStr Study of the effectiveness of the drug Laennek in case of liver damage by palm oil in rats
title_full_unstemmed Study of the effectiveness of the drug Laennek in case of liver damage by palm oil in rats
title_short Study of the effectiveness of the drug Laennek in case of liver damage by palm oil in rats
title_sort study of the effectiveness of the drug laennek in case of liver damage by palm oil in rats
topic palm oil
steatohepatosis
human placenta hydrolysates
laennec
hepatoprotection
url https://www.pharmacokinetica.ru/jour/article/view/389
work_keys_str_mv AT tebogacheva studyoftheeffectivenessofthedruglaennekincaseofliverdamagebypalmoilinrats
AT agkalacheva studyoftheeffectivenessofthedruglaennekincaseofliverdamagebypalmoilinrats
AT oagromova studyoftheeffectivenessofthedruglaennekincaseofliverdamagebypalmoilinrats
AT iyutorshin studyoftheeffectivenessofthedruglaennekincaseofliverdamagebypalmoilinrats
AT trgrishina studyoftheeffectivenessofthedruglaennekincaseofliverdamagebypalmoilinrats
AT videmidov studyoftheeffectivenessofthedruglaennekincaseofliverdamagebypalmoilinrats